Glibenclamide Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 1.25 mg, 2.5 mg, 5 mg
Reference Brands:
Category:
Diabetes
libenclamide Tablet is a medicine that is used for the treatment of Type 2 Diabetes Mellitus and other conditions.
Glibenclamide Tablet contains Glibenclamide as an active ingredient.
Glibenclamide Tablet works by promoting the insulin secretion in the body.
Glibenclamide Tablets is available in Tablets
and strengths such as 1.25 mg, 2.5 mg, 5 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Glibenclamide Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Glibenclamide Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Glibenclamide Tablet is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms:
· Type 2 Diabetes Mellitus
Glibenclamide Tablet Working, Mechanism of Action and Pharmacology
Glibenclamide Tablet improves the patient's condition by performing the following functions:
· Promoting the insulin secretion in the body.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing